Prognostic significance of loss of c-fos protein in gastric carcinoma

Pathology and Oncology Research

Volumn 13, Issue 4, 2007, Pages 284-289

  Jin, Seon Pil ^a   Kim, Ji Hun ^a   Kim, Min A ^a   Yang, Han Kwang ^a   Lee, Hee Eun ^b   Lee, Hye Seung ^b   Kim, Woo Ho ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Immunohistochemistry; Proto oncogene protein c fos; Stomach neoplasms; Survival analysis; Tissue array analysis; Tumor suppressor protein

Indexed keywords

PROTEIN C FOS;

ADULT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE C FOS; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CARCINOMA;

EID: 39649116426     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02940306     Document Type: Article

References (32)

1. Halazonetis TD, Georgopoulos K, Greenberg ME, Leder P: c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 55: 917-924, 1988
2. Schutte J, Viallet J, Nau M, Segal S, Fedorko J, Minna J: jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 59: 987-997, 1989
3. Bakin AV, Curran T: Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 283: 387-390, 1999
4. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF: Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 122: 685-701, 1993
5. Hu E, Mueller E, Oliviero S, Papaioannou VE, Johnson R, Spiegelman BM: Targeted disruption of the c-fos gene demonstrates c-fos dependent and independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J 13: 3094-3103, 1994
6. Fialka I, Schwarz H, Reichmann E, Oft M, Busslinger M, Beug H: The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J Cell Biol 132: 1115-1132, 1996
7. Franchi A, Calzolari A, Zampi G: Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumours of the skeleton. Virchows Arch 432: 515-519, 1998
8. Papachristou DJ, Batistatou A, Sykiotis GP, Varakis I, Papavassiliou AG: Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 32: 364-371, 2003
9. Gamberi G, Benassi MS, Bohling T, Ragazzini P, Molendini L, Sollazzo MR, Pompetti F, Merli M, Magagnoli G, Balladelli A, Picci P: C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression. Oncology 55: 556-563, 1998
10. Bamberger AM, Milde-Langosch K, Rossing E, Goemann C, Loning T: Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J Cancer Res Clin Oncol 127: 545-550, 2001
11. Prusty BK, Das BC: Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 113: 951-960, 2005
12. Yuen MF, Wu PC, Lai VC, Lau JY, Lai CL: Expression of c-Myc, c-Fos and c-Jun in hepatocellular carcinoma. Cancer 91: 106-112, 2001
13. Wakita K, Ohyanagi H, Yamamoto K, Tokuhisa T, Saitoh Y: Overexpression of c-Ki-ras and c-fos in human pancreatic carcinomas. Int J Pancreatol 11: 43-47, 1992
14. Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ: Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg 221: 706-718, 1995
15. Mikula M, Gotzmann J, Fischer AN, Wolschek MF, Thallinger C, Schulte-Hermann R, Beug H, Mikulits W: The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. Oncogene 22: 6725-6738, 2003
16. American Joint Committee on Cancer: AJCC cancer staging manual 6th ed. Springer-Verlag, New York, 2002
17. International Agency for Research on Cancer (IARC): World Health Organization Classification of Tumors; pathology and genetics of tumors of the digestive system. IARC Press, Lyon, 2000
18. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH: MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 92: 1427-1434, 2001
19. Nevine S, Darwish, Kim MA, Chang MS, Lee HS, Lee BL, Kim YI, Kim WH: Prognostic significance of CD24 expression in gastric carcinoma. Cancer Res Treat 36: 298-302, 2004
20. Kustikova O, Kramerov D, Grigorian M, Berezin V, Bock E, Lukanidin E, Tulchinsky E: Fra-1 induces morphological transformation and increases in vitro invasiveness and mobility of epithelioid adenocarcinoma cells. Mol Cell Biol 18: 7095-7105, 1998
21. Levin WJ, Press MF, Gaynor RB, Sukhatme VP, Boone TC, Reissmann PT, Figlin RA, Holmes EC, Souza LM, Slamon DJ: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene 11: 1261-1269, 1995
22. Liu G, Takano T, Matsuzuka F, Higashiyama T, Kuma K, Amino N: Screening of specific changes in mRNAs in thyroid tumors by sequence specific differential display: decreased expression of c-fos mRNA in papillary carcinoma. Endocr J 46: 459-466, 1999
23. Fleischmann A, Jochum W, Eferl R, Witowsky J, Wagner EF: Rhabdomyosarcoma development in mice lacking Trp53 and Fos: tumor suppression by the Fos protooncogene. Cancer Cell 4: 477-482, 2003
24. Grimm C, Wenzel A, Behrens A, Hafezi F, Wagner EF, Reme CE: AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun. Cell Death Differ 8: 859-867, 2001
25. Kalra N, Kumar V: c-Fos is a mediator of the c-myc-induced apoptotic signaling in serum-deprived hepatoma cells via the p38 mitogen-activated protein kinase pathway. J Biol Chem 279: 25313-25319, 2004
26. Silvers AL, Bachelor MA, Bowden GT: The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression. Neoplasia 5: 319-329, 2003
27. Siegmund D, Mauri D, Peters N, Juo P, Thome M, Reichwein M, Blenis J, Scheurich P, Tschopp J, Wajant H: Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway. J Biol Chem 276: 32585-32590, 2001
28. Willaime S, Vanhoutte P, Caboche J, Lemaigre-Dubreuil Y, Mariani J, Brugg B: Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur J Neurosci 13: 2037-2046, 2001
29. Kondo T, Sharp FR, Honkaniemi J, Mikawa S, Epstein CJ, Chan PH: DNA fragmentation and prolonged expression of c-fos, c-jun, and hsp70 in kainic acid-induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase. J Cereb Blood Flow Metab 17: 241-256, 1997
30. Hasegawa K, Litt L, Espanol MT, Sharp FR, Chan PH: Expression of c-fos and hsp70 mRNA in neonatal rat cerebrocortical slices during NMDA-induced necrosis and apoptosis. Brain Res 785: 262-278, 1998
31. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl HL: Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem 275: 16064-16072, 2000
32. Myllykangas S, Monni O, Nagy B, Rautelin H, Knuutila S: Helicobacter pylori infection activates FOS and stress-response genes and alters expression of genes in gastric cancer-specific loci. Genes Chromosomes Cancer 40: 334-341, 2004